Interventions to mitigate risk of cardiovascular disease after adverse pregnancy outcomes: a review
AR Jowell, AA Sarma, M Gulati, ED Michos… - JAMA …, 2022 - jamanetwork.com
Importance A growing body of evidence suggests that adverse pregnancy outcomes (APOs),
including hypertensive disorders of pregnancy, gestational diabetes (GD), preterm birth, …
including hypertensive disorders of pregnancy, gestational diabetes (GD), preterm birth, …
Increasing Participation of Women in Cardiovascular Trials: JACC Council Perspectives
…, ML O'Donoghue, MO Ogunniyi, AA Sarma… - Journal of the American …, 2021 - jacc.org
Although some progress has been made in the last 3 decades to increase the number of
women in clinical cardiology trials, review of recent cardiovascular literature demonstrates that …
women in clinical cardiology trials, review of recent cardiovascular literature demonstrates that …
Outcomes of women compared with men after non–ST-segment elevation acute coronary syndromes
AA Sarma, E Braunwald, CP Cannon, J Guo… - Journal of the American …, 2019 - jacc.org
Background : It remains disputed whether women are at excess risk of adverse outcomes
versus men after non–ST-segment elevation acute coronary syndromes (NSTEACS) or …
versus men after non–ST-segment elevation acute coronary syndromes (NSTEACS) or …
Cardiovascular medicine and society: the pregnant cardiologist
AA Sarma, C Nkonde-Price, M Gulati… - Journal of the American …, 2017 - jacc.org
Women are a consistent minority in the field of cardiology, with concerns regarding balancing
career and parenting responsibilities often cited as a contributing factor to this under-…
career and parenting responsibilities often cited as a contributing factor to this under-…
Galectin-3 inhibition with modified citrus pectin in hypertension
ES Lau, E Liu, SM Paniagua, AA Sarma… - Basic to Translational …, 2021 - jacc.org
We investigated the effect of galectin-3 (Gal-3) inhibition with modified citrus pectin on
markers of collagen metabolism in a proof-of-concept randomized placebo-controlled trial of …
markers of collagen metabolism in a proof-of-concept randomized placebo-controlled trial of …
[HTML][HTML] 10 recommendations to enhance recruitment, retention, and career advancement of women cardiologists
—Timmis et al.(1) Women are markedly underrepresented in cardiology relative to the rest
of medicine despite nearly equal representation with men in internal medicine residency …
of medicine despite nearly equal representation with men in internal medicine residency …
Genetic variation in cardiometabolic traits and medication targets and the risk of hypertensive disorders of pregnancy
…, M Chaffin, K Aragam, DL Bhatt, MJ Wood, AA Sarma… - Circulation, 2020 - Am Heart Assoc
CORRESPONDENCE with HDP. Results were unchanged in analyses restricted to 180 846
women with White British ancestry. Twosample Mendelian randomization using the inverse …
women with White British ancestry. Twosample Mendelian randomization using the inverse …
The Utilization and Interpretation of Cardiac Biomarkers During Pregnancy: JACC: Advances Expert Panel
AA Sarma, NR Aggarwal, JE Briller, M Davis… - JACC: Advances, 2022 - jacc.org
Cardiac biomarkers are widely used in the nonpregnant population when acute cardiovascular
(CV) pathology is suspected; however, the behavior of these biomarkers in the context of …
(CV) pathology is suspected; however, the behavior of these biomarkers in the context of …
Developmental dynamics of piriform cortex
AA Sarma, MB Richard, CA Greer - Cerebral cortex, 2011 - academic.oup.com
The piriform cortex (PCX) is a trilaminar paleocortex that is of interest for its role in odor coding
and as a model for studying general principles of cortical sensory processing. While the …
and as a model for studying general principles of cortical sensory processing. While the …
[HTML][HTML] Echocardiography for the pregnant heart
HA Afari, EF Davis, AA Sarma - Current Treatment Options in …, 2021 - Springer
Purpose of review Pregnancy is associated with significant hemodynamic changes, making
it a potentially high-risk period for women with underlying cardiovascular disease. …
it a potentially high-risk period for women with underlying cardiovascular disease. …